Viridian Therapeutics Inc
NASDAQ:VRDN

Watchlist Manager
Viridian Therapeutics Inc Logo
Viridian Therapeutics Inc
NASDAQ:VRDN
Watchlist
Price: 20.2 USD 2.96% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Viridian Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Viridian Therapeutics Inc

Current Assets 767.4m
Cash & Short-Term Investments 753.2m
Receivables 14k
Other Current Assets 14.1m
Non-Current Assets 4.5m
PP&E 3.7m
Other Non-Current Assets 853k
Current Liabilities 41.4m
Accounts Payable 6.3m
Accrued Liabilities 34.7m
Other Current Liabilities 288k
Non-Current Liabilities 23m
Long-Term Debt 20.5m
Other Non-Current Liabilities 2.5m

Balance Sheet
Viridian Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
5
11
22
47
33
25
46
42
156
103
Cash Equivalents
5
11
22
47
33
25
46
42
156
103
Short-Term Investments
0
0
0
0
30
2
82
155
269
375
Total Receivables
1
0
0
2
0
0
0
1
0
0
Accounts Receivables
1
0
0
2
0
0
0
1
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
2
3
3
3
2
3
7
9
Total Current Assets
7
12
24
52
65
30
130
200
431
486
PP&E Net
1
1
1
1
1
1
1
2
3
3
PP&E Gross
1
1
1
1
1
1
1
2
3
3
Accumulated Depreciation
1
1
3
3
3
3
3
2
2
1
Other Long-Term Assets
0
0
0
0
0
0
1
2
1
1
Total Assets
8
N/A
13
+59%
25
+92%
53
+112%
66
+26%
30
-54%
131
+333%
204
+55%
435
+114%
490
+13%
Liabilities
Accounts Payable
0
0
1
1
1
1
1
2
14
2
Accrued Liabilities
0
1
4
3
4
5
10
11
19
24
Short-Term Debt
0
1
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
2
0
2
4
0
0
0
0
Other Current Liabilities
1
0
0
0
0
0
0
0
0
0
Total Current Liabilities
2
3
7
4
7
10
11
14
33
27
Long-Term Debt
0
0
3
10
8
4
0
0
5
20
Other Liabilities
0
0
0
0
0
0
1
2
2
2
Total Liabilities
2
N/A
3
+19%
10
+288%
14
+44%
15
+6%
15
-2%
11
-23%
16
+43%
40
+150%
48
+21%
Equity
Common Stock
0
0
77
0
0
0
181
134
143
207
Retained Earnings
7
18
67
94
126
168
279
358
488
726
Additional Paid In Capital
13
28
5
132
177
184
218
412
741
961
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
6
N/A
10
+73%
15
+45%
39
+155%
51
+33%
16
-69%
120
+659%
188
+56%
395
+110%
442
+12%
Total Liabilities & Equity
8
N/A
13
+59%
25
+92%
53
+112%
66
+26%
30
-54%
131
+333%
204
+55%
435
+114%
490
+13%
Shares Outstanding
Common Shares Outstanding
0
0
0
2
2
2
4
24
41
54
Preferred Shares Outstanding
0
0
0
0
0
0
0
1
0
0

See Also

Discover More